House Speaker David Ralston just finished a drop-by at a breakfast reception hosted by Georgia Bio, a consortium of academic and business interests engaged in life science research.
The group has been the primary opponent of legislation such as S.B. 169, a bill to put limits on embryonic stem cell research – beyond the federal regulations recently recast by the Obama administration.
The bill passed the Senate last year, but never made it out of the House Science and Technology Committee.
Ralston’s appearance at Georgia Bio was brief and budget-oriented. But afterwards, the House speaker was asked whether S.B. 169 would move this session. Ralston could have said that he was too concentrated on the state’s financial problems to think about such things.
He did not. Said Ralston:
“I think this is an important discussion. I haven’t taken a position on that bill, or this group’s work. I think that’s something we can bring people to the table [on] and have a positive discussion. Because I think it’s an issue we need to talk about. And we’re going as we go through the session.”
For instant updates, follow me on Twitter.